SCHEMBL6288675

SCHEMBL6288675

Oc1cc2cnc(Br)cc2cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31444206 0.76 CYP1A2 (0.46)
SCHEMBL2749215 0.76 ABL1 (0.47)
SCHEMBL31650080 0.73
SCHEMBL31649678 0.73
SCHEMBL18769920 0.71 HSD17B10 (0.35)
SCHEMBL18769955 0.71 L3MBTL1 (0.31)
SCHEMBL16937583 0.71 MAPT (0.43)
SCHEMBL2671761 0.71 GSK3A (0.45)
SCHEMBL6288666 0.70 ESR2 (0.34)
SCHEMBL8339944 0.70 CYP1A2 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6974822-B2 3-isoquinolinone derivatives as matrix metalloproteinase inhibitors WARNER-LAMBERT COMPANY LLC (US) 2005-12-13 US disclosed
US-20040038959-A1 3-Isoquinolinone derivatives as matrix metalloproteinase inhibitors BUNKER AMY MAE (US) 2004-02-26 US disclosed
WO-2004014378-A1 3-ISOQUINOLINONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIITORS WARNER-LAMBERT COMPANY LLC (US) 2004-02-19 WO disclosed